NADSYN1

NADSYN1
Identifiers
Aliases	NADSYN1, NAD synthetase 1, VCRL3
External IDs	OMIM: 608285 MGI: 1926164 HomoloGene: 6098 GeneCards: NADSYN1
Gene location (Human) Chr. Chromosome 11 (human) Band 11q13.4 Start 71,453,109 bp End 71,524,107 bp
Gene location (Mouse) Chr. Chromosome 7 (mouse) Band 7|7 F5 Start 143,349,321 bp End 143,376,586 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in right uterine tube anterior pituitary minor salivary glands right lung rectum body of stomach right lobe of thyroid gland left uterine tube spleen left lobe of thyroid gland Top expressed in duodenum jejunum proximal tubule yolk sac left lobe of liver colon ileum kidney left colon epithelium of stomach More reference expression data BioGPS More reference expression data
Gene ontology Molecular function nucleotide binding ligase activity protein binding ATP binding glutaminase activity NAD+ synthase (glutamine-hydrolyzing) activity Cellular component cytoplasm cytosol Biological process nitrogen compound metabolic process NAD metabolic process NAD biosynthetic process Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 55191 78914 Ensembl ENSG00000172890 ENSMUSG00000031090 UniProt Q6IA69 Q711T7 RefSeq (mRNA) NM_018161 NM_030221 NM_001308092 NM_001308095 RefSeq (protein) NP_060631 NP_001295024 NP_084497 Location (UCSC) Chr 11: 71.45 – 71.52 Mb Chr 7: 143.35 – 143.38 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Glutamine-dependent NAD(+) synthetase is an enzyme that in humans is encoded by the NADSYN1 gene.

Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).

Further reading

• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
• Dias Neto E, Correa RG, Verjovski-Almeida S, et al. (2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3491–6. Bibcode:2000PNAS...97.3491D. doi:10.1073/pnas.97.7.3491. PMC 16267. PMID 10737800.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
• Lehner B, Sanderson CM (2004). "A Protein Interaction Framework for Human mRNA Degradation". Genome Res. 14 (7): 1315–23. doi:10.1101/gr.2122004. PMC 442147. PMID 15231747.
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
• Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.